Remove Development Remove Marketing Remove Pharma Companies Remove Production
article thumbnail

Laurus Labs and IIT Kanpur partner for new gene therapy products

Pharmaceutical Technology

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Laurus Labs will be responsible for launching these products in India and emerging markets.

article thumbnail

Benefits of PCD Pharma Company

Fossil Remedies

In the pharma sector, running a PCD Pharma Company in India guarantees good returns. It can help you in developing an undeniable and profitable business by offering a well-established platform. What is a PCD Pharma Company? Here are Some Unique Benefits of PCD Pharma Company. #1

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Product launch metrics are changing in pharma

World of DTC Marketing

The old model of looking at performance in the first six months of product launch isn’t relevant. Today, colossal budget product launches are not returning the same ROI as before. Product launches are going to need to be micro-targeted to specific audiences. What is the definition of a successful pharma product launch?

article thumbnail

The biggest transformation in pharma marketing since DTC

World of DTC Marketing

This is an exciting time to be in healthcare marketing. We’re witnessing the most significant transformation in healthcare marketing since DTC was approved in the ’90s. is no more an option but the critical factor to ensure success for any multichannel marketing initiatives.

Marketing 202
article thumbnail

Multichannel Marketing: Coordinating Digital Efforts for Pharma Success

Pharma Marketing Network

Multichannel marketing is an effective digital strategy for pharmaceutical companies to reach consumers and encourage them to purchase products. In this article, we will explore the concept of multichannel marketing, discuss digital strategies for pharma success, and examine the benefits and challenges of this approach.

article thumbnail

Takeda discontinuing in AAV and rare haematology disease markets

Pharmaceutical Technology

The company is aiming to refocus its efforts on its core therapeutic areas and current late-stage programmes such as the oral TYK2 inhibitor TAK-279, which is under development for several autoimmune disorders.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.